Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Category: Diabetes

2525-P: HbA1c Determines Serum Proteomic Response to Acute Exercise in Type 1 Diabetes

June 21, 2026 by sugaradmin

Introduction and Objective: High HbA1c is linked to lower aerobic exercise capacity (VO2peak), even when exercise-training levels are matched, suggesting hyperglycemia may alter the adaptive response to exercise. Each acute bout of exercise induces changes in circulating proteins that mediate exercise response. We determined how T1D alters circulating proteins at rest and with exercise and […]

Read More
DiabetesLeave a Comment on 2525-P: HbA1c Determines Serum Proteomic Response to Acute Exercise in Type 1 Diabetes

1016-OR: Continuous Glucose Monitoring (CGM) Coverage Policy, Access, and Utilization in Nonprofit Community Health Plans

June 21, 2026 by sugaradmin

Introduction and Objective: The Alliance of Community Health Plans (ACHP) is a nonprofit trade association representing nonprofit community health plans. To advance its Chronic Disease Pledge to improve diabetes outcomes by 2030, ACHP members worked together with the International Diabetes Center to understand payer policies related to continuous glucose monitoring (CGM). This project, supported by […]

Read More
DiabetesLeave a Comment on 1016-OR: Continuous Glucose Monitoring (CGM) Coverage Policy, Access, and Utilization in Nonprofit Community Health Plans

2524-P: Acute Glycemic Variability and Outcome in Sepsis: A Prospective Study

June 21, 2026 by sugaradmin

Introduction and Objective: Emerging evidence suggests that glycemic variability may influence outcomes in sepsis. Our objective was to investigate the correlation between acute glycemic variability and mortality as well as other clinical outcomes in sepsis.Methods: Patients aged 18 years or older with sepsis were enrolled in this prospective observational study during 2024-2025. Capillary blood glucose […]

Read More
DiabetesLeave a Comment on 2524-P: Acute Glycemic Variability and Outcome in Sepsis: A Prospective Study

1656-P: TEPLI-REAL: A Real-World Retrospective Study Characterizing Screening and Treatment Patterns for Type 1 Diabetes (T1D) in Individuals Treated with Teplizumab in the U.S.

June 21, 2026 by sugaradmin

Introduction and Objective: Teplizumab (TPZ), an anti-CD3 monoclonal antibody, is approved in the US to delay stage 3 T1D onset in individuals aged ≥8 years (y) with stage 2 T1D. We present screening and real-world treatment (Tx) patterns from individuals in the US who received TPZ according to their age group.Methods: TEPLI-REAL (NCT06892002) was a […]

Read More
DiabetesLeave a Comment on 1656-P: TEPLI-REAL: A Real-World Retrospective Study Characterizing Screening and Treatment Patterns for Type 1 Diabetes (T1D) in Individuals Treated with Teplizumab in the U.S.

2523-P: Early Glycemic Deterioration and Baseline Risk Prediction of Insulin-Like Growth Factor-1 Receptor Inhibitor Therapy

June 21, 2026 by sugaradmin

Introduction and Objective: Insulin-like growth factor-1 receptor (IGF-1R) inhibitor has been developed as an effective therapy for thyroid eye disease (TED). However, treatment-associated hyperglycemia remains a clinical concern. We aimed to examine whether early glycemic deterioration during IGF-1R inhibitor therapy is associated with subsequent glycemic trajectories and to develop and validate a risk prediction model.Methods: […]

Read More
DiabetesLeave a Comment on 2523-P: Early Glycemic Deterioration and Baseline Risk Prediction of Insulin-Like Growth Factor-1 Receptor Inhibitor Therapy

1561-P: Physical Activity Goal Attainment among Women Veterans Participants in Virtual Diabetes Prevention Program (DPP): The Role of Session Completion, Self-Monitoring, and Social Interactions

June 21, 2026 by sugaradmin

Introduction and Objective: The Diabetes Prevention Program’s (DPP) standardized goal of ≥150 mins of physical activity (PA)/week leads to long-term health benefits. We examined the association between virtual DPP PA goal attainment and three distinct program engagement components: session completion, self-monitoring, and social interactions.Methods: We included women Veterans participating in virtual DPP across 11 VA […]

Read More
DiabetesLeave a Comment on 1561-P: Physical Activity Goal Attainment among Women Veterans Participants in Virtual Diabetes Prevention Program (DPP): The Role of Session Completion, Self-Monitoring, and Social Interactions

3110-LB: RNF20, an Epigenetic Modifier, Is Essential for Pancreatic Organogenesis and Neonatal Islet Function

June 21, 2026 by sugaradmin

Introduction and Objective: Pancreatic islets maintain glucose homeostasis, with diabetes mellitus arising from autoimmune destruction (T1D) or dysregulation (T2D) of insulin-producing pancreatic β-cells. While exogenous insulin treats T1D, transplanted stem cell-derived islet-like cells may offer improved glycemic control with fewer long-term complications. However, a better understanding of pancreas and islet development is needed for successfully […]

Read More
DiabetesLeave a Comment on 3110-LB: RNF20, an Epigenetic Modifier, Is Essential for Pancreatic Organogenesis and Neonatal Islet Function

1425-P: Modelling Vascular Dysfunction in Lean Type 2 Diabetes Using IPSC-Derived Endothelial Cells Under Metabolic Stress

June 21, 2026 by sugaradmin

Introduction and Objective: Although obesity is a major driver of type 2 diabetes (T2D), lean T2D represents 3-8% of global cases and remains understudied. Diabetes-associated cardiovascular disease is well characterized; vascular modeling of lean T2D is limited. We aim to determine whether induced pluripotent stem cell (iPSC)-derived endothelial cells from patients with lean T2D exhibit […]

Read More
DiabetesLeave a Comment on 1425-P: Modelling Vascular Dysfunction in Lean Type 2 Diabetes Using IPSC-Derived Endothelial Cells Under Metabolic Stress

1067-OR: A Multicenter Trial Assessing the Efficacy and Safety of the Novel Twiist Automated Insulin Delivery (AID) System in Adults with Insulin-Treated Type 2 Diabetes (T2D)

June 21, 2026 by sugaradmin

Introduction and Objective: Despite GLP1ra or SGLT2i therapy, many adults with insulin treated type 2 diabetes (T2D) remain above HbA1c targets. AID may provide benefit for T2D. The study objective was to evaluate efficacy and safety of the twiist AID system, which uses the novel twiist pump and Tidepool Loop algorithm, in adults with insulin-treated […]

Read More
DiabetesLeave a Comment on 1067-OR: A Multicenter Trial Assessing the Efficacy and Safety of the Novel Twiist Automated Insulin Delivery (AID) System in Adults with Insulin-Treated Type 2 Diabetes (T2D)

2800-LB: Virtual Diabetes Self-Management Environment on Perceived Social Support and Clinical Outcomes in Adults with Type 2 Diabetes: A 12-Month Secondary Analysis of a Randomized Controlled Trial

June 21, 2026 by sugaradmin

Introduction and Objective: Virtual environments may enhance social support through interactive and immersive engagement; however, evidence of their long-term impact remains limited. This study aims to examine the effect of a 3D virtual diabetes self-management education and support (DSME/S) intervention (Learning in a Virtual Environment [LIVE]) on perceived social support and its association with behavioral […]

Read More
DiabetesLeave a Comment on 2800-LB: Virtual Diabetes Self-Management Environment on Perceived Social Support and Clinical Outcomes in Adults with Type 2 Diabetes: A 12-Month Secondary Analysis of a Randomized Controlled Trial

Posts navigation

Older posts
Newer posts

Recent Posts

  • Many Obesity Drugs Do Not Improve Quality of Life
  • Prevalence, incidence, mortality, and years of life lost to diabetes from 1996 to 2024 in Denmark
  • Smelling Chocolate May Help Boost Workouts, Reduce Hunger
  • No Link To Prenatal Tylenol Use, Studies Confirm
  • Getting 78 Fewer Minutes of Sleep a Night May Lead to Weight Gain

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness